Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence

Giustozzi, M; Verso, M; Agnelli, G; Becattini, C

Giustozzi, M (reprint author), Univ Perugia, Internal Vasc & Emergency Med & Stroke Unit, Via G Dottori 1, I-06129 Perugia, Italy.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017; 44 (4): 527

Abstract

Major bleeding occurs in about 4% of patients while on treatment with direct oral anticoagulants (DOACs). The case-fatality rate associated with these......

Full Text Link